Attached files
| file | filename |
|---|---|
| 10-K - 10-K - Adamas Pharmaceuticals Inc | adms1231201710k.htm |
| EX-32.1 - EXHIBIT 32.1 - Adamas Pharmaceuticals Inc | adms10k2017ex321.htm |
| EX-31.2 - EXHIBIT 31.2 - Adamas Pharmaceuticals Inc | adms10k2017ex312.htm |
| EX-31.1 - EXHIBIT 31.1 - Adamas Pharmaceuticals Inc | adms10k2017ex311.htm |
| EX-10.38 - EXHIBIT 10.38 - Adamas Pharmaceuticals Inc | adms10k2017ex1038.htm |
| EX-10.37 - EXHIBIT 10.37 - Adamas Pharmaceuticals Inc | adms10k2017ex1037.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statement on Form S-3 (No. 333-214409) and Form S-8 (Nos. 333-216313, 333-210255, 333-202467 and 333-195384) of Adamas Pharmaceuticals, Inc. of our report dated February 22, 2018 relating to the financial statements, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
San Jose, California
February 22, 2018